Parietal-hippocampal rTMS improves cognitive function in Alzheimer's disease and increases dynamic functional connectivity of default mode network
•A double-blind, randomized, sham-controlled, fMRI-guided rTMS trial.•Individualized rTMS over the parietal region is effective in treating Alzheimer's disease.•fMRI-guided rTMS treatment improves patients’ cognitive performance.•fMRI-guided rTMS treatment enhances functional connectivity of DM...
Saved in:
Published in | Psychiatry research Vol. 315; p. 114721 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
01.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | •A double-blind, randomized, sham-controlled, fMRI-guided rTMS trial.•Individualized rTMS over the parietal region is effective in treating Alzheimer's disease.•fMRI-guided rTMS treatment improves patients’ cognitive performance.•fMRI-guided rTMS treatment enhances functional connectivity of DMN.•IMPROVED cognitive function is related to enhanced DMN functional connectivity.
Parietal-hippocampal repetitive transcranial magnetic stimulation (rTMS) improves cognitive function in Alzheimer's disease (AD), however, the underlying therapeutic mechanism has not been elucidated. A double-blind, randomized, sham-controlled parietal-hippocampal rTMS trial (five sessions/week for a total of 10 sessions) of mild-to-moderate AD patients was conducted in the study. High-frequency rTMS was applied to a subject-specific left lateral parietal region with the highest functional connectivity with the hippocampus based on resting-state fMRI. A multimodal MRI scan and a complete neuropsychological battery of tests were conducted at baseline, immediately after the intervention and 12-week follow-up after the rTMS treatment. Compared to sham treatment (n = 27), patients undergoing active rTMS treatment (n = 29) showed higher Mini Mental State Examination (MMSE) score and dynamic functional connectivity (dFC) magnitude of the default mode network (DMN) after two weeks of rTMS treatment, but not at 12-week follow-up. A significant positive correlation was observed between changes in MMSE and changes in the dFC magnitude of DMN in patients who underwent active-rTMS treatment, but not in those who received sham-rTMS treatment. The findings of the current study indicate that fMRI-guided rTMS treatment improves cognitive function of AD patients in the short term, and DMN functional connectivity contributes to therapeutic effectiveness of rTMS. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ISSN: | 0165-1781 1872-7123 1872-7123 |
DOI: | 10.1016/j.psychres.2022.114721 |